LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through innovative medical technologies, delivering life-changing improvements for both the Head and Heart. Headquartered in London, LivaNova employs approximately 4,000 employees and has a presence in more than 100 countries for the benefit of patients, healthcare professionals and healthcare systems worldwide.
Company profile
Ticker
LIVN
Exchange
Website
CEO
Damien McDonald
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Integer • Masimo • Natus Medical • GigCapital5 • Outset Medical • Fonar • Cutera ...
Former names
Sand Holdco Plc
SEC CIK
Corporate docs
Subsidiaries
Caisson Interventional, LLC • CardiacAssist, Inc. • Cyberonics Holdings, LLC • ALung Technologies, Inc. • ImThera Medical, Inc. • LivaNova Australia PTY Limited • LivaNova Austria GmbH • LivaNova Belgium N.V. • LivaNova Brasil Comércio e Distribuição de Equipamentos Médico-hospitalares Ltda • LivaNova Canada, Inc. ...
LIVN stock data
Latest filings (excl ownership)
8-K
Regulation FD Disclosure
24 Mar 23
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
27 Feb 23
10-K
2022 FY
Annual report
27 Feb 23
8-K
LivaNova Reports Fourth-Quarter and Full-Year 2022 Results
22 Feb 23
8-K
Regulation FD Disclosure
17 Feb 23
8-K
Regulation FD Disclosure
19 Jan 23
8-K
Departure of Directors or Certain Officers
14 Dec 22
8-K
Other Events
13 Dec 22
8-K
Regulation FD Disclosure
28 Nov 22
8-K
Regulation FD Disclosure
15 Nov 22
Transcripts
LIVN
Earnings call transcript
2022 Q4
22 Feb 23
LIVN
Earnings call transcript
2022 Q3
2 Nov 22
LIVN
Earnings call transcript
2022 Q2
7 Aug 22
LIVN
Earnings call transcript
2022 Q1
8 May 22
LIVN
Earnings call transcript
2021 Q4
23 Feb 22
LIVN
Earnings call transcript
2021 Q3
6 Nov 21
LIVN
Earnings call transcript
2021 Q2
28 Jul 21
LIVN
Earnings call transcript
2021 Q1
1 May 21
LIVN
Earnings call transcript
2020 Q4
24 Feb 21
LIVN
Earnings call transcript
2020 Q3
31 Oct 20
Latest ownership filings
4
Marco Dolci
1 Mar 23
4
Trui Hebbelinck
1 Mar 23
4
Damien McDonald
1 Mar 23
SC 13G/A
HARRIS ASSOCIATES L P
14 Feb 23
SC 13G/A
PRIMECAP MANAGEMENT CO/CA/
9 Feb 23
SC 13G/A
BlackRock Inc.
26 Jan 23
SC 13G/A
BlackRock Inc.
20 Jan 23
4
Damien McDonald
19 Dec 22
4
Michael Damon Hutchinson
19 Dec 22
4
Alex Shvartsburg
19 Dec 22
Financial summary
| Quarter (USD) | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 515.62 mm | 515.62 mm | 515.62 mm | 515.62 mm | 515.62 mm | 515.62 mm |
| Cash burn (monthly) | (no burn) | (no burn) | (no burn) | 6.40 mm | (no burn) | (no burn) |
| Cash used (since last report) | n/a | n/a | n/a | 19.30 mm | n/a | n/a |
| Cash remaining | n/a | n/a | n/a | 496.32 mm | n/a | n/a |
| Runway (months of cash) | n/a | n/a | n/a | 77.6 | n/a | n/a |
Institutional ownership, Q4 2022
| 13F holders | Current |
|---|---|
| Total holders | 216 |
| Opened positions | 33 |
| Closed positions | 28 |
| Increased positions | 96 |
| Reduced positions | 60 |
| 13F shares | Current |
|---|---|
| Total value | 3.01 tn |
| Total shares | 54.82 mm |
| Total puts | 359.10 k |
| Total calls | 176.90 k |
| Total put/call ratio | 2.0 |
| Largest owners | Shares | Value |
|---|---|---|
| BLK Blackrock | 6.83 mm | $379.59 bn |
| Primecap Management | 4.59 mm | $255.20 bn |
| STT State Street | 2.64 mm | $146.60 bn |
| Barrow Hanley Mewhinney & Strauss | 2.32 mm | $128.78 bn |
| Harris Associates L P | 2.01 mm | $111.53 bn |
| Eminence Capital | 1.74 mm | $96.49 bn |
| MS Morgan Stanley | 1.65 mm | $91.63 bn |
| Vanguard | 1.48 mm | $82.31 bn |
| Hawk Ridge Capital Management | 1.28 mm | $70.92 bn |
| Redmile | 1.11 mm | $61.45 bn |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 27 Feb 23 | Marco Dolci | Ordinary Shares | Payment of exercise | Dispose F | No | No | 47.99 | 758 | 36.38 k | 5,679 |
| 27 Feb 23 | Marco Dolci | Ordinary Shares | Option exercise | Acquire M | No | No | 0 | 1,761 | 0.00 | 6,437 |
| 27 Feb 23 | Marco Dolci | Ordinary Shares | Payment of exercise | Dispose F | No | No | 47.99 | 1,801 | 86.43 k | 4,676 |
| 27 Feb 23 | Marco Dolci | Ordinary Shares | Option exercise | Acquire M | No | No | 0 | 4,188 | 0.00 | 6,477 |
| 27 Feb 23 | Marco Dolci | Performance Stock Units Ordinary Shares | Option exercise | Dispose M | No | No | 0 | 1,761 | 0.00 | 0 |
| 27 Feb 23 | Marco Dolci | Performance Stock Units Ordinary Shares | Option exercise | Dispose M | No | No | 0 | 4,188 | 0.00 | 0 |
| 27 Feb 23 | Hebbelinck Trui | Ordinary Shares | Payment of exercise | Dispose F | No | No | 47.99 | 663 | 31.82 k | 5,755 |
| 27 Feb 23 | Hebbelinck Trui | Ordinary Shares | Option exercise | Acquire M | No | No | 0 | 1,409 | 0.00 | 6,418 |
| 27 Feb 23 | Hebbelinck Trui | Ordinary Shares | Payment of exercise | Dispose F | No | No | 47.99 | 1,575 | 75.58 k | 5,009 |
| 27 Feb 23 | Hebbelinck Trui | Ordinary Shares | Option exercise | Acquire M | No | No | 0 | 3,350 | 0.00 | 6,584 |